Why the study?
Does β-pyridylcarbinol reduce ST-segment elevation during acute coronary occlusion in normal and reserpinized dogs?
Population
Normal and reserpinized dogs undergoing acute coronary occlusion
Comparison
β-pyridylcarbinol administration vs Acute coronary occlusion without β-pyridylcarbinol
Design
Preclinical
Follow-up
acute
Authors
Loading...
Indicates catecholamine-dependent lipolysis exacerbates ischemic injury in dogs; leaves open translation to human acute coronary syndromes.
Does β-pyridylcarbinol reduce ST-segment elevation during acute coronary occlusion in normal and reserpinized dogs?
Inhibition of lipolysis reduces ischemic injury during coronary occlusion only when myocardial catecholamine stores are intact, suggesting catecholamine-induced lipolysis contributes to ischemic injury.
John Kjekshus (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: